Gut,
Год журнала:
2024,
Номер
73(8), С. 1376 - 1387
Опубликована: Май 22, 2024
Background
Metabolic
disorders
and
inflammatory
bowel
diseases
(IBD)
have
captured
the
globe
during
Westernisation
of
lifestyle
related
dietary
habits
over
last
decades.
Both
disease
entities
are
characterised
by
complex
heterogeneous
clinical
spectra
linked
to
distinct
symptoms
organ
systems
which,
on
a
first
glimpse,
do
not
many
commonalities
in
practice.
However,
experimental
studies
indicate
common
backbone
mechanisms
metabolic
gut
inflammation,
emerging
evidence
suggests
an
intricate
interplay
between
IBD.
Objective
We
depict
parallels
IBD
diseases,
easily
overlooked
routine.
Design
provide
overview
recent
literature
discuss
implications
morbidity
patients
with
for
researchers,
clinicians
healthcare
providers.
Conclusion
The
Western
diet
microbial
perturbation
serve
as
fuel
inflammation
beyond
gut.
syndrome
increasingly
affect
IBD,
expected
negative
impact
both
risk
complications.
This
concept
implies
that
tackling
obesity
pandemic
exerts
beneficial
effects
health.
Frontiers in Endocrinology,
Год журнала:
2023,
Номер
14
Опубликована: Апрель 21, 2023
The
prevalence
of
obesity
and
diabetes
mellitus
(DM)
has
been
consistently
increasing
worldwide.
Sharing
powerful
genetic
environmental
features
in
their
pathogenesis,
amplifies
the
impact
susceptibility
factors
on
DM.
ectopic
expansion
adipose
tissue
excessive
accumulation
certain
nutrients
metabolites
sabotage
metabolic
balance
via
insulin
resistance,
dysfunctional
autophagy,
microbiome-gut-brain
axis,
further
exacerbating
dysregulation
immunometabolism
through
low-grade
systemic
inflammation,
leading
to
an
accelerated
loss
functional
β-cells
gradual
elevation
blood
glucose.
Given
these
intricate
connections,
most
available
treatments
type
2
DM
(T2DM)
have
a
mutual
effect
each
other.
For
example,
anti-obesity
drugs
can
be
anti-diabetic
some
extent,
medicines,
contrast,
shown
increase
body
weight,
such
as
insulin.
Meanwhile,
surgical
procedures,
especially
bariatric
surgery,
are
more
effective
for
both
T2DM.
Besides
guaranteeing
availability
accessibility
all
diagnostic
therapeutic
tools,
clinical
experimental
investigations
pathogenesis
two
diseases
warranted
improve
efficacy
safety
newly
developed
treatments.
Acta Pharmaceutica Sinica B,
Год журнала:
2023,
Номер
13(6), С. 2403 - 2424
Опубликована: Янв. 13, 2023
The
occurrence
of
obesity
has
increased
across
the
whole
world.
Many
epidemiological
studies
have
indicated
that
strongly
contributes
to
development
cancer,
cardiovascular
diseases,
type
2
diabetes,
liver
diseases
and
other
disorders,
accounting
for
a
heavy
burden
on
public
health-care
systems
every
year.
Excess
energy
uptake
induces
adipocyte
hypertrophy,
hyperplasia
formation
visceral
fat
in
non-adipose
tissues
evoke
disease,
diseases.
Adipose
tissue
can
also
secrete
adipokines
inflammatory
cytokines
affect
local
microenvironment,
induce
insulin
resistance,
hyperglycemia,
activate
associated
signaling
pathways.
This
further
exacerbates
progression
obesity-associated
Although
some
progress
treatment
been
achieved
preclinical
clinical
studies,
pathogenesis
obesity-induced
are
complex
unclear.
We
still
need
understand
their
links
better
guide
In
this
review,
we
review
between
with
view
improve
future
management
its
co-morbidities.
Signal Transduction and Targeted Therapy,
Год журнала:
2023,
Номер
8(1)
Опубликована: Ноя. 27, 2023
Abstract
Psoriasis
is
a
common,
chronic,
and
inflammatory
skin
disease
with
high
burden
on
individuals,
health
systems,
society
worldwide.
With
the
immunological
pathologies
pathogenesis
of
psoriasis
becoming
gradually
revealed,
therapeutic
approaches
for
this
have
gained
revolutionary
progress.
Nevertheless,
mechanisms
less
common
forms
remain
elusive.
Furthermore,
severe
adverse
effects
recurrence
upon
treatment
cessation
should
be
noted
addressed
during
treatment,
which,
however,
has
been
rarely
explored
integration
preliminary
findings.
Therefore,
it
crucial
to
comprehensive
understanding
behind
pathogenesis,
which
might
offer
new
insights
research
lead
more
substantive
progress
in
expand
clinical
options
treatment.
In
review,
we
looked
briefly
introduce
epidemiology,
subtypes,
pathophysiology,
comorbidities
systematically
discuss
signaling
pathways
involving
extracellular
cytokines
intracellular
transmission,
as
well
cross-talk
between
them.
discussion,
also
paid
attention
potential
metabolic
epigenetic
molecular
mechanistic
cascades
related
its
comorbidities.
This
review
outlined
current
psoriasis,
especially
targeted
therapies
novel
strategies,
mechanism
recurrence.
Seminars in Cancer Biology,
Год журнала:
2023,
Номер
92, С. 16 - 27
Опубликована: Март 24, 2023
Excess
body
weight
is
a
global
health
problem
due
to
sedentary
lifestyle
and
unhealthy
diet,
affecting
2
billion
population
worldwide.
Obesity
major
risk
factor
for
metabolic
diseases.
Notably,
the
of
obesity
largely
depends
on
distribution,
which
visceral
adipose
tissues
but
not
subcutaneous
fats
are
closely
associated
with
comorbidities,
including
type
diabetes,
non-alcoholic
fatty
liver
disease,
cardiovascular
disease
certain
types
cancer.
Latest
multi-omics
mechanistical
studies
reported
crucial
involvement
genetic
epigenetic
alterations,
adipokines
dysregulation,
immunity
changes,
imbalance
white
brown
tissues,
gut
microbial
dysbiosis
in
mediating
pathogenic
association
between
comorbidities.
In
this
review,
we
explore
epidemiology
excess
up-to-date
mechanism
how
lead
chronic
complications.
We
also
examine
utilization
fat
measurement
as
an
accurate
clinical
parameter
assessment
healthy
individuals
outcome
prediction
obese
subjects.
addition,
current
approaches
prevention
treatment
its
related
comorbidities
further
discussed.
World Journal of Diabetes,
Год журнала:
2023,
Номер
14(3), С. 130 - 146
Опубликована: Март 15, 2023
Insulin
resistance
and
pancreatic
β-cell
dysfunction
are
major
pathological
mechanisms
implicated
in
the
development
progression
of
type
2
diabetes
(T2D).
Beyond
detrimental
effects
insulin
resistance,
inflammation
oxidative
stress
have
emerged
as
critical
features
T2D
that
define
dysfunction.
Predominant
markers
such
C-reactive
protein,
tumor
necrosis
factor
alpha,
interleukin-1β
consistently
associated
with
failure
preclinical
models
people
T2D.
Similarly,
important
stress,
increased
reactive
oxygen
species
depleted
intracellular
antioxidants,
consistent
damage
conditions
Such
illustrate
a
relationship
between
an
abnormal
inflammatory
response
generation
during
The
current
review
explores
clinical
research
on
patho-logical
implications
Moreover,
molecular
relevant
biomarkers
involved
this
process
discussed
to
divulge
link
Underpinning
relevance
review,
systematic
analysis
evidence
from
randomized
controlled
trials
is
covered,
potential
therapeutic
some
commonly
used
antidiabetic
agents
modulating
makers
improve
function.
Annual Review of Physiology,
Год журнала:
2022,
Номер
85(1), С. 339 - 362
Опубликована: Сен. 22, 2022
High
iron
is
a
risk
factor
for
type
2
diabetes
mellitus
(T2DM)
and
affects
most
of
its
cardinal
features:
decreased
insulin
secretion,
resistance,
increased
hepatic
gluconeogenesis.
This
true
across
the
normal
range
tissue
levels
in
pathologic
overload.
Because
iron's
central
role
metabolic
processes
(e.g.,
fuel
oxidation)
regulation
hypoxia
sensing),
participate
determining
rates,
gluconeogenesis,
choice,
action,
adipocyte
phenotype.
The
related
to
evident
or
all
tissues
that
determine
phenotypes,
with
adipocyte,
beta
cell,
liver
playing
roles.
Molecular
mechanisms
these
effects
are
diverse,
although
there
may
be
integrative
pathways
at
play.
Elucidating
has
implications
not
only
prevention
treatment,
but
also
pathogenesis
other
diseases
are,
like
T2DM,
associated
aging,
nutrition,
iron.
Frontiers in Endocrinology,
Год журнала:
2023,
Номер
14
Опубликована: Фев. 7, 2023
Diabetes
mellitus
(DM)
is
a
metabolic
disease
characterized
by
chronic
hyperglycaemia,
with
absolute
insulin
deficiency
or
resistance
as
the
main
cause,
and
causes
damage
to
various
target
organs
including
heart,
kidney
neurovascular.
In
terms
of
pathological
physiological
mechanisms
DM,
oxidative
stress
one
leading
DM
an
important
link
between
its
complications.
Oxidative
phenomenon
resulting
from
imbalance
production
free
radicals
scavenging
antioxidant
systems.
The
site
reactive
oxygen
species
(ROS)
mitochondria,
which
are
also
organelles
damaged.
high
glucose
environment,
impaired
electron
transport
chain
within
mitochondria
leads
ROS,
prompts
increased
proton
leakage
altered
mitochondrial
membrane
potential
(MMP),
in
turn
releases
cytochrome
c
(cyt-c),
apoptosis.
This
subsequently
vicious
cycle
clearance
body's
system,
transcription
protein
synthesis
DNA
(mtDNA),
responsible
for
encoding
proteins,
repair
systems,
contributing
dysfunction.
paper
reviews
dysfunction
environment
induced
model,
looks
forward
providing
new
treatment
plan
based
on
International Journal of Molecular Sciences,
Год журнала:
2023,
Номер
24(11), С. 9317 - 9317
Опубликована: Май 26, 2023
Baicalin
is
one
of
the
most
abundant
flavonoids
found
in
dried
roots
Scutellaria
baicalensis
Georgi
(SBG)
belonging
to
genus
Scutellaria.
While
baicalin
demonstrated
have
anti-inflammatory,
antiviral,
antitumor,
antibacterial,
anticonvulsant,
antioxidant,
hepatoprotective,
and
neuroprotective
effects,
its
low
hydrophilicity
lipophilicity
limit
bioavailability
pharmacological
functions.
Therefore,
an
in-depth
study
baicalin’s
pharmacokinetics
contributes
laying
theoretical
foundation
for
applied
research
disease
treatment.
In
this
view,
physicochemical
properties
anti-inflammatory
activity
are
summarized
terms
bioavailability,
drug
interaction,
inflammatory
conditions.